{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:48:34Z","timestamp":1773971314534,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["SOP-159230"],"award-info":[{"award-number":["SOP-159230"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jbc.2025.111107","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T16:14:20Z","timestamp":1766506460000},"page":"111107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sphingosine-1-phosphate receptor 2 inhibition ameliorates familial exudative vitreoretinopathy models"],"prefix":"10.1016","volume":"302","author":[{"given":"Hirad A.","family":"Feridooni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Fody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7962-3566","authenticated-orcid":false,"given":"Mahtab","family":"Tavasoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Alkandari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"van der Ende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3884-7026","authenticated-orcid":false,"given":"Michel","family":"Nader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3172-854X","authenticated-orcid":false,"given":"Johane M.","family":"Robitaille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher R.","family":"McMaster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.111107_bib1","series-title":"Norrie disease and Other Developmental Retinal Vascular Disorders in Genetic Diseases of the Eye","first-page":"504","article-title":"Familial exudative vitreoretinopathy (FEVR)","author":"Robitaille","year":"2011"},{"key":"10.1016\/j.jbc.2025.111107_bib2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/ng957","article-title":"Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy","volume":"32","author":"Robitaille","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2025.111107_bib3","series-title":"Norrie disease and Other Developmental Retinal Vascular Disorders in Genetic Diseases of the Eye","first-page":"504","author":"Robitaille","year":"2011"},{"key":"10.1016\/j.jbc.2025.111107_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/iovs.62.15.4","article-title":"Ocular features and mutation spectrum of patients with familial exudative Vitreoretinopathy","volume":"62","author":"Tao","year":"2021","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jbc.2025.111107_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.11.001","article-title":"Retinal vasculature development in health and disease","volume":"63","author":"Selvam","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jbc.2025.111107_bib6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng1093-180","article-title":"A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy","volume":"5","author":"Chen","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2025.111107_bib7","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ajhg.2016.02.017","article-title":"Mutations in TSPAN12 cause autosomal-dominant familial exudative vitreoretinopathy","volume":"98","author":"Poulter","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jbc.2025.111107_bib8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/jamaophthalmol.2022.2914","article-title":"Severe familial exudative vitreoretinopathy, congenital hearing loss, and developmental delay in a child with biallelic variants in FZD4","volume":"140","author":"van der Ende","year":"2022","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.jbc.2025.111107_bib9","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1086\/425080","article-title":"Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5","volume":"75","author":"Jiao","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jbc.2025.111107_bib10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1086\/383202","article-title":"Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q","volume":"74","author":"Toomes","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jbc.2025.111107_bib11","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/cge.14499","article-title":"Severe isolated exudative vitreoretinopathy caused by biallelic FZD4 variants","volume":"105","author":"Hoem","year":"2024","journal-title":"Clin. Genet."},{"key":"10.1016\/j.jbc.2025.111107_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1167\/iovs.66.2.23","article-title":"Gene variant spectrum in probands with familial exudative vitreoretinopathy using an expanded panel","volume":"66","author":"van der Ende","year":"2025","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jbc.2025.111107_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cell.2009.07.048","article-title":"TSPAN12 regulates retinal vascular development by promoting Norrin- but not Wnt-induced FZD4\/beta-catenin signaling","volume":"139","author":"Junge","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.111107_bib14","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1101\/gad.228544.113","article-title":"Structure and function of Norrin in assembly and activation of a frizzled 4-Lrp5\/6 complex","volume":"27","author":"Ke","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbc.2025.111107_bib15","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/j.celrep.2017.06.004","article-title":"TSPAN12 is a norrin Co-receptor that amplifies Frizzled4 ligand selectivity and signaling","volume":"19","author":"Lai","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2025.111107_bib16","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.1038\/s41467-024-52174-z","article-title":"Structural basis of Frizzled 4 in recognition of dishevelled 2 unveils mechanism of WNT signaling activation","volume":"15","author":"Qian","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.111107_bib17","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2012.10.042","article-title":"Norrin\/Frizzled4 signaling in retinal vascular development and blood brain barrier plasticity","volume":"151","author":"Wang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.111107_bib18","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0092-8674(04)00216-8","article-title":"Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair","volume":"116","author":"Xu","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.111107_bib19","doi-asserted-by":"crossref","first-page":"e158428","DOI":"10.1172\/jci.insight.158428","article-title":"CTNND1 variants cause familial exudative vitreoretinopathy through the Wnt\/cadherin axis","volume":"7","author":"Yang","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.jbc.2025.111107_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2009.07.047","article-title":"Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization","volume":"139","author":"Ye","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.111107_bib21","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1161\/ATVBAHA.118.311689","article-title":"Endothelial cell-specific inactivation of TSPAN12 (Tetraspanin 12) reveals pathological consequences of barrier defects in an otherwise intact vasculature","volume":"38","author":"Zhang","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jbc.2025.111107_bib22","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.1167\/iovs.10-7146","article-title":"Frizzled 4 is required for retinal angiogenesis and maintenance of the blood-retina barrier","volume":"52","author":"Paes","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jbc.2025.111107_bib23","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41586-018-0447-x","article-title":"Crystal structure of the Frizzled 4 receptor in a ligand-free state","volume":"560","author":"Yang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.111107_bib24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.molmed.2010.07.003","article-title":"The Norrin\/Frizzled4 signaling pathway in retinal vascular development and disease","volume":"16","author":"Ye","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jbc.2025.111107_bib25","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.1111\/aos.14586","article-title":"Early detection of ocular abnormalities in a Chinese multicentre neonatal eye screening programme-1-year result","volume":"99","author":"Fei","year":"2021","journal-title":"Acta. Ophthalmol."},{"key":"10.1016\/j.jbc.2025.111107_bib26","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1136\/bjophthalmol-2021-319115","article-title":"Sphingosine 1-phosphate, a potential target in neovascular retinal disease","volume":"106","author":"Alshaikh","year":"2022","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jbc.2025.111107_bib27","doi-asserted-by":"crossref","first-page":"eaar5551","DOI":"10.1126\/science.aar5551","article-title":"Sphingosine 1-phosphate: lipid signaling in pathology and therapy","volume":"366","author":"Cartier","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jbc.2025.111107_bib28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.devcel.2012.08.005","article-title":"The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2","volume":"23","author":"Gaengel","year":"2012","journal-title":"Dev. Cell"},{"key":"10.1016\/j.jbc.2025.111107_bib29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2025.111107_bib30","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.devcel.2012.07.015","article-title":"Flow-regulated endothelial S1P receptor-1 signaling sustains vascular development","volume":"23","author":"Jung","year":"2012","journal-title":"Dev. Cell"},{"key":"10.1016\/j.jbc.2025.111107_bib31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0092-8674(00)81661-X","article-title":"Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate","volume":"99","author":"Lee","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.111107_bib32","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.3390\/ijms19123885","article-title":"Characterizing sphingosine kinases and sphingosine 1-Phosphate receptors in the Mammalian eye and Retina","volume":"19","author":"Porter","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2025.111107_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112197","article-title":"Updates on sphingolipids: spotlight on retinopathy","volume":"143","author":"Shiwani","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jbc.2025.111107_bib34","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1172\/JCI31123","article-title":"Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina","volume":"117","author":"Skoura","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2025.111107_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104775","article-title":"Sphingosine-1-phosphate and its receptors in vascular endothelial and lymphatic barrier function","volume":"299","author":"Weigel","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.111107_bib36","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.devcel.2020.01.016","article-title":"Sphingosine 1-Phosphate receptor signaling establishes AP-1 gradients to allow for retinal endothelial cell specialization","volume":"52","author":"Yanagida","year":"2020","journal-title":"Dev. Cell"},{"key":"10.1016\/j.jbc.2025.111107_bib37","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/blood-2012-11-467191","article-title":"Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation","volume":"122","author":"Zhang","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2025.111107_bib38","doi-asserted-by":"crossref","first-page":"7893","DOI":"10.1038\/ncomms8893","article-title":"Critical role of sphingosine-1-phosphate receptor-2 in the disruption of cerebrovascular integrity in experimental stroke","volume":"6","author":"Kim","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.111107_bib39","first-page":"23","article-title":"Gene variant spectrum in probands with familial exudative vitreoretinopathy","volume":"66","author":"van der Ende","year":"2025","journal-title":"IOVS"},{"key":"10.1016\/j.jbc.2025.111107_bib40","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216645","article-title":"Therapeutic activation of endothelial sphingosine-1-phosphate receptor 1 by chaperone-bound S1P suppresses proliferative retinal neovascularization","volume":"15","author":"Niaudet","year":"2023","journal-title":"EMBO. Mol. Med."},{"key":"10.1016\/j.jbc.2025.111107_bib41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jss.2021.03.006","article-title":"JTE-013 alleviates inflammatory injury and endothelial dysfunction induced by sepsis in vivo and in vitro","volume":"265","author":"Xu","year":"2021","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.jbc.2025.111107_bib42","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1161\/ATVBAHA.111.235408","article-title":"Pericyte-derived sphingosine 1-phosphate induces the expression of adhesion proteins and modulates the retinal endothelial cell barrier","volume":"31","author":"McGuire","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jbc.2025.111107_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158320","article-title":"Fzd4 haploinsufficiency delays retinal revascularization in the mouse model of oxygen induced retinopathy","volume":"11","author":"Ngo","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2025.111107_bib44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/13816810903479834","article-title":"Severe retinopathy of prematurity associated with FZD4 mutations","volume":"31","author":"Ells","year":"2010","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.jbc.2025.111107_bib45","first-page":"476","article-title":"Genetic variants of FZD4 and LRP5 genes in patients with advanced retinopathy of prematurity","volume":"19","author":"Kondo","year":"2013","journal-title":"Mol. Vis."},{"key":"10.1016\/j.jbc.2025.111107_bib46","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.ophtha.2015.05.036","article-title":"Frizzled-4 variations associated with retinopathy and intrauterine growth retardation: a potential marker for prematurity and retinopathy","volume":"122","author":"Dailey","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jbc.2025.111107_bib47","article-title":"A Norrin\/Wnt surrogate antibody stimulates endothelial cell barrier function and rescues retinopathy EMBO","volume":"13","author":"Chidiac","year":"2021","journal-title":"Mol. Med."},{"key":"10.1016\/j.jbc.2025.111107_bib48","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1038\/s41467-023-37689-1","article-title":"Therapeutic blood-brain barrier modulation and stroke treatment by a bioengineered FZD(4)-selective WNT surrogate in mice","volume":"14","author":"Ding","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.111107_bib49","doi-asserted-by":"crossref","first-page":"e1546","DOI":"10.21769\/BioProtoc.1546","article-title":"Mouse retinal whole mounts and quantification of vasculature protocol","volume":"5","author":"Adini","year":"2015","journal-title":"Bio. Protoc."},{"key":"10.1016\/j.jbc.2025.111107_bib50","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/978-3-031-47606-8_40","article-title":"ImageJ in computational fractal-based neuroscience: pattern extraction and translational Research","volume":"36","author":"Karperien","year":"2024","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/j.jbc.2025.111107_bib51","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/pro.3993","article-title":"The ImageJ ecosystem: Open-source software for image visualization, processing, and analysis","volume":"30","author":"Schroeder","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.jbc.2025.111107_bib52","doi-asserted-by":"crossref","DOI":"10.1111\/micc.12618","article-title":"REAVER: a program for improved analysis of high-resolution vascular network images","volume":"27","author":"Corliss","year":"2020","journal-title":"Microcirculation"},{"key":"10.1016\/j.jbc.2025.111107_bib53","doi-asserted-by":"crossref","DOI":"10.1111\/micc.12520","article-title":"Methods to label, image, and analyze the complex structural architectures of microvascular networks","volume":"26","author":"Corliss","year":"2019","journal-title":"Microcirculation"},{"key":"10.1016\/j.jbc.2025.111107_bib54","doi-asserted-by":"crossref","first-page":"37","DOI":"10.12688\/wellcomeopenres.16619.1","article-title":"BoneJ2 - refactoring established research software","volume":"6","author":"Domander","year":"2021","journal-title":"Wellcome Open Res."},{"key":"10.1016\/j.jbc.2025.111107_bib55","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1039\/c3ib40085a","article-title":"The mouse retina in 3D: quantification of vascular growth and remodeling","volume":"5","author":"Milde","year":"2013","journal-title":"Integr. Biol. (Camb)"},{"key":"10.1016\/j.jbc.2025.111107_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027385","article-title":"A computational tool for quantitative analysis of vascular networks","volume":"6","author":"Zudaire","year":"2011","journal-title":"PLoS One"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582502959X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582502959X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:30:17Z","timestamp":1773966617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002192582502959X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S002192582502959X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.111107","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sphingosine-1-phosphate receptor 2 inhibition ameliorates familial exudative vitreoretinopathy models","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.111107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"111107"}}